Published on
The COVID-19 pandemic has posed new and unfamiliar challenges to those delivering care to pregnant women and their fetuses. Healthcare providers have been challenged to balance the risks of COVID-19 exposure with the potential negative impact that delayed intervention could have on maternal, fetal and/or neonatal outcomes. A recently released statement by the North American Fetal Therapy Network (NAFTNet) offers evidence-based guidance to help balance these risks.
“Fetal therapy is not elective, and it is time sensitive,” says statement co-author, Julie S. Moldenhauer, MD, Director of Obstetrical Services at CHOP’s Center for Fetal Diagnosis and Treatment. “This statement was a collaborative effort by fetal therapy experts across the continent to provide guidance so we are able to continue to provide fetal care to women who need it during the current crisis.”
NAFTNet continues to closely monitor the evolving information around the COVID-19 pandemic and will update practice guidelines accordingly.
Access the full statement here.
Reference
Fetal Interventions in the Setting of COVID-19 Pandemic: Statement from the North American Fetal Therapy Network (NAFTNet). Bahtiyar MO, Baschat A, Deprest J, Emery S, Goodnight W, Johnson A, McCullough L, Moldenhauer J, Ryan G, Tsao K, Van Mieghem T, Wagner A, Zaretsky M, on behalf of NAFTNet. Am J Obstet Gynecol. 2020 April; doi: https:// doi.org/10.1016/j.ajog.2020.04.025.
